期刊文献+

亚临床原发性醛固酮增多症合并亚临床库欣综合征1例并文献复习

A case report of subclinical primary aldosterone complicating with subclinical Cushing syndrome and literature review
原文传递
导出
摘要 本文报告1例罕见的亚临床原发性醛固酮增多症(subclinical primary aldosteronism,SPA)合并亚临床库欣综合征(subclinical Cushing syndrome,SCS)患者。该患者为41岁的女性,因肾上腺偶发瘤(adrenal incidentaloma,AI)入院。患者无高血压、低血钾、糖代谢异常等典型的原发性醛固酮增多症(primary aldosteronism,PA)或库欣综合征(Cushing syndrome,CS)的临床表现,实验室检查示醛固酮肾素比值(aldosterone to renin ratio,ARR)>3.7,促肾上腺皮质激素(adrenocorticotropic hormone,ACTH)<1.6 pg/mL,最终依据术后病理学检查结果,患者被诊断为肾上腺皮质腺瘤。该病例中存在2种亚临床疾病共存的诊断,这种临床类型在目前的指南和报道中并未得到充分认识,值得关注并进行更详细的讨论。 This case reports a rare subclinical primary aldosteronism complicated with subclinical Cushing’s syndrome.A 41-year-old female patient was admitted for adrenal incidentaloma,had no clinical manifestations of typical primary aldosteronism or Cushing syndrome,such as hypertension,hypokalemia,abnormal glucose metabolism.Laboratory tests indicated ARR>3.7,ACTH<1.6 pg/mL,and a postoperative pathological diagnosis was adrenal cortical adenoma.Subclinical coexistence of both diseases was presented in this case.This type is not fully recognized in current guidelines and reports,and deserves more detailed discussion.
作者 侯怡茹 王敏 王春花 陈俞洁 HOU Yiru;WANG Min;WANG Chunhua;CHEN Yujie(School of Clinical Medicine,Shandong Second Medical University,Shandong Weifang 261000,China;Qilu Hospital of Shandong University,Dezhou Hospital,Department of General Medicine,Shandong Dezhou 253000,China)
出处 《诊断学理论与实践》 2023年第5期480-485,共6页 Journal of Diagnostics Concepts & Practice
关键词 肾上腺偶发瘤 亚临床原发性醛固酮增多症 亚临床库欣综合征 Adrenal incidentaloma Subclinical primary aldosteronism Subclinical Cushing syndrome
  • 相关文献

参考文献6

二级参考文献30

  • 1Androulakis II, Kaltsas G, Piaditis G, et al. The clinical significance of adrenal incidentalomas [ J ]. Eur J Clin Invest, 2011,41 (5) :552-560.
  • 2Chiodini L. Clinical review : diagnosis and treatment of subclinical hypercortisolism[ J ]. J Clin Endocrinol Metab, 2011, 96 (5) : 1223-1236.
  • 3Terzolo M, Pia A, Reimondo G. Subclinical Cushing's Syndrome: definition and management [ J ]. Clin Endocrinol (Oxf), 2012, 76(1) :12-18.
  • 4Zeiger MA, Thompson GB, Duh QY, et al. The American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons medical guidelines for the management of adrenal incidentalomas[ J ]. Endocr Pract, 2009, 15 ( Suppl 1 ) : 1-20.
  • 5Terzolo M, Stigliano A, Chiodini I, et al. AME position statementon adrenal incidentaloma[J]. Eur J Endocrinol, 2011, 164(6) : 851-870.
  • 6Mantero F, Terzolo M, Arnaldi G, et al. A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology [ J ]. J Clin Endocrinol Metab, 2000, 85(2) :637-644.
  • 7Valli N, Catargi B, Ronci N, et al. Biochemical screening for subclinical cortisol-seereting adenomas amongst adrenal incidentaloma[ J]. Eur J Endocrinol, 2001, 144(4) :401-408.
  • 8Hamrahian AH, Ioachimescu AG, Remer EM, et al. Clinical utility of noneontrast computed tomography value (hounsfield units ) to differentiate adrenal adenomas/hyperplasias from nonadenomas : Cleveland Clinic experience [ J ]. J Clin Endocrinol Metab, 2005, 90(2) :871-877.
  • 9Reinmondo G, Allasino B, Bovio S, et al. Pros and cons of dexamethasone suppression test for screening of subclinical Cushing's syndrome in patients with adrenal incidentalomas [ J ]. J Endocrinol Invest, 2011, 34( 1 ) :el-e5.
  • 10Nieman LK, Biller BM, Findling JW, et al. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline[ J ]. J Clin Endocrinol Metab, 2008, 93 (5) : 1526- 1540.

共引文献171

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部